Technical Updates, Management Changes, Financial Results, and Dividends - Research Reports on U.S. Bancorp, Health Care REIT, Invesco, Hartford and CME Group

NEW YORK, August 13, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding U.S. Bancorp (NYSE: USB), Health Care REIT, Inc. (NYSE: HCN), Invesco Ltd. (NYSE: IVZ), Hartford Financial Services Group Inc. (NYSEQ: HIG) and CME Group Inc. (NASDAQ: CME). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5700-100free.

--
U.S. Bancorp Research Reports
On August 8, 2014, U.S. Bancorp's (U.S. Bancorp) stock moved up 1.23% to end the trading session at $41.18, outperforming the S&P 500 that moved up 1.15% over the same trading session. Shares in U.S. Bancorp opened the session at $40.78 and oscillated in the range of $40.68 - $41.20. The stock has a 52-week high of $43.92 and a 52-week low of $35.69. Over the past three months and six months, the stock has returned 2.13% and 2.95%, respectively. The full research reports on U.S. Bancorp are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/USB/report.pdf

--
Health Care REIT, Inc. Research Reports
On August 6, 2014, Health Care REIT, Inc. (Health Care REIT) announced several executive promotions, changes in titles and role expansions, effective July 31, 2014. Scott M. Brinker, previously Executive Vice President (EVP)-Investments, has been named EVP - Chief Investment Officer; Scott A. Estes remains EVP - CFO with additional responsibility of managing the Company's legal and Tax teams, resources and processes; Charles J. Herman, Jr. has been named as the EVP - President, Seniors Housing and Post-Acute; Erin C. Ibele has been promoted to EVP - Head of Human Capital and Corporate Secretary; Jeffrey H. Miller has been named as EVP - Chief Operating Officer; and Jay Morgan has been promoted to the post of Senior Vice President - Head of Medical Facilities Group. In addition, Mike Crabtree will continue as Executive Officer of the Company reporting to Scott Estes, and serving as Senior Vice President and Corporate Treasurer. The full research reports on Health Care REIT are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/HCN/report.pdf

--
Invesco Ltd. Research Reports
On July 31, 2014, Invesco Ltd. (Invesco) released its Q2 2014 and H1 2014 financial results. The Company reported Q2 2014 total operating revenues of $1.3 billion, up 13.6% YoY. During the quarter, the Company's investment management fees revenue improved 16.5% YoY to $1.0 billion; service and distribution fees revenue declined 0.5% YoY to $214.7 million; performance fees revenue declined 16.7% YoY to $5.0 million; and other revenue improved 35.3% YoY to $38.3 million. In Q2 2014, the Company's average assets under management (AUM) improved 9.8% YoY to $790.1 billion. The Company's Q2 2014 net income attributable to common shareholders came in at $274.5 million or $0.63 per diluted share, compared to $202.6 million or $0.45 per diluted share in Q2 2013. The Company's H1 2014 total operating revenues improved 13.9% YoY to $2.6 billion, while net income attributable to common shareholders improved 8.8% YoY to $462.3 million. The full research reports on Invesco are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/IVZ/report.pdf

--
Hartford Financial Services Group Inc. Research Reports
On July 30, 2014, Hartford Financial Services Group Inc. (Hartford) reported Q2 2014 total revenues of $4.6 billion, down 2.5% YoY. During the quarter, the Company's core earnings declined 37.7% YoY to $144 million as the increase in core earnings from Property & Casualty (P&C) Commercial, Group Benefits and Mutual Funds was more than offset by higher prior year loss and loss adjustment expense reserve development for asbestos and environmental compared with Q2 2013. The Company's Q2 2014 net loss widened to $467 million or $1.00 per diluted share, from $190 million or $0.39 per diluted share in Q2 2013. The Company stated that its Q2 2014 net loss includes a loss of $617 million on discontinued operations, after-tax, from the sale of the Company's Japan annuity business. Analysts polled by Thomson Reuters expected the Company to report Q2 2014 EPS of $0.68 (excluding special items) on revenues of $5.40 billion. The full research reports on Hartford are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/HIG/report.pdf

--
CME Group Inc. Research Reports
On August 6, 2014, CME Group Inc. (CME Group) announced a $0.47 per share dividend for Q3 2014, payable on September 25, 2014, to shareholders of record as of September 10, 2014. The recently announced dividend is unchanged from the dividend announced in the previous quarter. The full research reports on CME Group are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/CME/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED